Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

GIOTRIF DIN 02415666

Status: Marketed
Holder: BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Molecule: AFATINIB (AFATINIB DIMALEATE)

Health Canada record

Active ingredient(s)AFATINIB (AFATINIB DIMALEATE) 20 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01EB03 AFATINIB
Original market date17-Jan-2014
Current status date17-Jan-2014
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing AFATINIB (AFATINIB DIMALEATE)

DINProductCompanyFormStrengthStatus
02415674GIOTRIFBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletAFATINIB (AFATINIB DIMALEATE) 30 MGMarketed
02415682GIOTRIFBOEHRINGER INGELHEIM (CANADA) LTD LTEETabletAFATINIB (AFATINIB DIMALEATE) 40 MGMarketed
02517035MAR-AFATINIBMARCAN PHARMACEUTICALS INCTabletAFATINIB (AFATINIB DIMALEATE) 40 MGMarketed
02517019MAR-AFATINIBMARCAN PHARMACEUTICALS INCTabletAFATINIB (AFATINIB DIMALEATE) 20 MGMarketed
02517027MAR-AFATINIBMARCAN PHARMACEUTICALS INCTabletAFATINIB (AFATINIB DIMALEATE) 30 MGMarketed
02512777SANDOZ AFATINIBSANDOZ CANADA INCORPORATEDTabletAFATINIB (AFATINIB DIMALEATE) 20 MGMarketed
02512785SANDOZ AFATINIBSANDOZ CANADA INCORPORATEDTabletAFATINIB (AFATINIB DIMALEATE) 30 MGMarketed
02512793SANDOZ AFATINIBSANDOZ CANADA INCORPORATEDTabletAFATINIB (AFATINIB DIMALEATE) 40 MGMarketed
02514591TEVA-AFATINIBTEVA CANADA LIMITEDTabletAFATINIB (AFATINIB DIMALEATE) 20 MGCancelled Pre Market
02514605TEVA-AFATINIBTEVA CANADA LIMITEDTabletAFATINIB (AFATINIB DIMALEATE) 30 MGCancelled Pre Market
02514613TEVA-AFATINIBTEVA CANADA LIMITEDTabletAFATINIB (AFATINIB DIMALEATE) 40 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
148732013-11-01New Drug Submission (NDS)
Request a quote for GIOTRIF

How to read a Canadian DIN record